Raymond James Financial Services Advisors, Inc. United Therapeutics Corp Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 6,429 shares of UTHR stock, worth $2.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,429
Previous 1,385
364.19%
Holding current value
$2.4 Million
Previous $441,000
422.22%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding UTHR
# of Institutions
669Shares Held
42.8MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$2.04 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.64 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.18 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.07 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$835 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $17B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...